FEMSelect
PrivateLast Round
Series B
Extension
May 13, 2025
Total Funding Raised
$14.3M
Company Overview
FEMSelect is a medical technology company that develops minimally invasive surgical systems for the treatment of pelvic organ prolapse.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FEMSelect Comparables
Compare FEMSelect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Escala Medical | 92% | |
| Neomedic International | 82% | |
| Caldera Medical | 80% |
FEMSelect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 13, 2025 | ||||
| Series B | Oct 19, 2022 | ||||
| Series A | Jan 24, 2018 | ||||
| Seed | Dec 1, 2012 |
Key People
Founding team and executive leadership
FEMSelect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordwand Capital | Series B Extension |
| TransPacific Venture Partners | Series B |
| Robin Hood Ventures | Series B Extension, Series B |
| Keiretsu Capital | Series B |
| MEDA Angels | Series B |
| Keiretsu Forum Mid-Atlantic | Series B |
| Triventures | Series B Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 41% MoM.
- Jun 6, 2025
Grew 25% QoQ from 12 to 15 employees.
FEMSelect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about FEMSelect's valuation, stock price, and market status.
Is FEMSelect a public or private company?
FEMSelect is a private company.
What is the current stock price of FEMSelect?
FEMSelect is a private company with no public stock price. No recent secondary market data is available.
How much is FEMSelect worth (valuation)?
Valuation information for FEMSelect is not publicly available.
Can I buy FEMSelect stock?
FEMSelect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was FEMSelect's last funding round?
FEMSelect's most recent funding round was Series B Extension on May 13, 2025.
Who are the main investors in FEMSelect?
Key investors in FEMSelect include Triventures, New Age Ventures, RAD BioMed.
Will FEMSelect IPO soon?
No public IPO plans have been announced for FEMSelect.
How can I track FEMSelect secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FEMSelect's secondary market activity and sign up for updates.